• DOI:10.1155/2005/242516
Corpus ID: 26017979

Pharmacokinetics of cannabinoids.

@article{Mcgilveray2005PharmacokineticsOC,
  title={Pharmacokinetics of cannabinoids.},
  author={I. Mcgilveray},
  journal={Pain research & management},
  year={2005},
  volume={10 Suppl A},
  pages={
          15A-22A
        }
}

• I. Mcgilveray
• Published 2005
• Chemistry, Medicine
• Pain research & management

Delta-9-tetrahydrocannabinol (Delta-9-THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC) and nabilone. The variability of THC in plant material (0.3% to 30%) leads to variability in tissue THC levels from smoking, which is, in itself, a highly individual process. THC… Expand

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed